share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 28 05:13
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 06/27/2024, as per the latest filing. The shares, valued at an aggregate market value of $43,290.18, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a recent history of transactions by Marriott Tina, who sold a total of 6,000 shares over the past three months, generating total gross proceeds of $49,345.50.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 06/27/2024, as per the latest filing. The shares, valued at an aggregate market value of $43,290.18, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a recent history of transactions by Marriott Tina, who sold a total of 6,000 shares over the past three months, generating total gross proceeds of $49,345.50.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.